Scientific opinion on the regulation of gene-edited plant products within the context of Division 28 of the Food and Drug Regulations (Novel Foods)
Health Canada has developed its scientific opinion regarding the regulation of gene-edited plant products within the context of the Novel Food Regulations. This opinion helped to inform the development of the Department's new Health Canada Guidance on the Novelty Interpretation of Products of Plant Breeding and Health Canada Guidance on the Pre-Market Assessment of Foods Derived from Retransformants.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2022-12-02
Data overview
- Formats
- HTML
- File languages
- English, French
Official sources and licences
Resources
- Scientific opinion on the regulation of gene-edited plant products within the context of Division 28 of the Food and Drug Regulations (Novel Foods) (English, HTML) HTML
- Scientific opinion on the regulation of gene-edited plant products within the context of Division 28 of the Food and Drug Regulations (Novel Foods) (French, HTML) HTML